Darnitsa Launched Facebook Tours of the Production Facilities

With the launch of tours on Facebook platform, Darnitsa Pharmaceutical Company broadened the project of online tours of the pharmaceutical production.

Due to the simplicity of the mechanics of one-click tours, the new format has already been tested by almost a thousand users of the social network. Darnitsa offers online tours of the production of various dosage forms of drugs in real time. Guests have the opportunity to watch live the process of creating medicines, ask questions and receive answers from competent professionals.

In 2021, the company announced three seasons of Facebook tours. During each season, users are offered online visits to various sites - of the production of drugs in ampoules, infusion solutions, solid dosage forms and robotic logistics complex. The program includes a visit to one production shop during one tour.

Andrii Obrizan, General Director of Darnitsa Pharmaceutical Company: “Darnitsa became the first company to eliminate all obstacles and invite to look behind the scenes of the production in real time. Last year, we launched online tours in Zoom as part of the platform for communication with consumers and continue improving it. In the conditions of the increased attention to the pharmaceutical industry, this gives confidence in proper conditions of manufacturing of medicines. The functionality of live broadcasts in social networks with a user notification system makes it possible to join the tour in time from any place and fully interact with the company's specialists.”

Prior to introduction of quarantine restrictions, Darnitsa was the first in the Ukrainian pharmaceutical market to open the production facilities and conduct regular tours for everyone. After the start of the pandemic, the company moved the tours to ZOOM platform with the possibility of registration on the corporate website.

Darnitsa Pharmaceutical Company has been the leader in Ukraine in terms of sales of medicines by volume since 1998. The company has 14 production lines certified according to the GMP standard. The company's portfolio consists of more than 260 names of finished drugs. Its strategic areas include cardiology, neurology and pain management. Darnitsa’s products are exported to 16 countries around the world. The beneficiaries of Darnitsa Pharmaceutical Company are the Zagoriy family.